Sato Vicki L
SEC-identified person · CIK 1197020 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Allogene Therapeutics, Inc. ALLO | Director | filed 2021–2026 |
| Vir Biotechnology, Inc. VIR | Director | filed 2019–2026 |
| Denali Therapeutics Inc. DNLI | Director | filed 2017–2025 |
| Akouos, Inc. AKUS | Director | filed 2020–2022 |
| Bristol Myers Squibb CO BMY | Director | filed 2006–2021 |
| Borgwarner INC bwa | Director | filed 2014–2020 |
| Syros Pharmaceuticals, Inc. SYRS | Director | filed 2016–2019 |
| Revvity, INC. RVTY | Director | filed 2006–2017 |
| Alnylam Pharmaceuticals, INC. ALNY | Director | filed 2007–2010 |
| Infinity Pharmaceuticals, INC. INFI | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.